Portal Developed Further for Hospitals

Mawdsleys’ hospital customers are already seeing the benefits of the latest developments to their dedicated portal, Mawdsleys Online.

 

Launched in February 2018, the improvements give hospitals even more efficiency in managing their wholesale back orders online, with enhanced functionality and additional information, and in product searches, such as by allowing our customers to more easily identify wholesale NHS contract products.

 

These changes were steered by feedback from our hospital customers, who we will continue to work closely with as we develop bespoke solutions to support hospitals.

 

Access Mawdsleys Online Here

 

Hospitals who don’t already have a log in for Mawdsleys Online (Wholesale or Unlicensed) – please request one by emailing helpdesk@mawdsleys.co.uk or calling 0161 742 3311

 

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-selected-as-distributors-for-morningside-pharmaceuticals-ltd/ thumbnail image Mawdsleys selected as distributors for Morningside Pharmaceuticals Ltd

Supplying quality pharmaceuticals and medical devices for over 20 years, we are very excited to be working alongside such a reputable manufacturer.   The Morningside Pharmaceuticals Ltd team commented   “Morningside are delighted to bring on board Mawdsleys to assist in the supply and distribution of our NHS contracted products.…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-oncoscience-launch-a-named-patient-program-for-cimaher-nimotuzumab-in-the-uk-and-ireland/ thumbnail image Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…

Read more